FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to a composition containing a c-Met antagonist representing an antibody, and an aminoheteroaryl compound and applicable for treating cancer. Besides, the group of inventions represents a pharmaceutical composition containing an anti-c-Met antibody and the aminoheteroaryl compound in the form of combination medications.
EFFECT: using the group of inventions provides more effective inhibition of cancer growth and prolonged absence of a tumour.
15 cl, 2 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-c-Met ANTIBODY | 2009 |
|
RU2560257C2 |
| NEW ANTIBODY TO c-Met | 2011 |
|
RU2607377C2 |
| NEW ANTIBODIES INHIBITING C-MET DIMERISATION AND USING THEM | 2008 |
|
RU2552161C2 |
| SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR | 2014 |
|
RU2671212C2 |
| ANTIBODIES TO B7-H3 AND CONJUGATES OF ANTIBODY AND DRUG | 2017 |
|
RU2764651C2 |
| C-MET/HGFR INHIBITOR POLYMORPHS | 2006 |
|
RU2387650C2 |
| 3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USE THEREOF IN TREATING DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 OF IKAROS (IKZF2) FAMILY | 2019 |
|
RU2815714C2 |
| METHOD OF TREATING ABNORMAL CELL EXPANSION | 2006 |
|
RU2384331C2 |
| PHOSPHORUS CONTAINING COMPOUNDS AS PROTEIN KINASE INHIBITORS | 2012 |
|
RU2598849C2 |
| 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 (IKZF2) OF THE IKAROS FAMILY | 2019 |
|
RU2797559C2 |
